Will you have Interstitial lung disease with Levoxyl - from FDA reports

Summary

Interstitial lung disease is found among people who take Levoxyl, especially for people who are female, 60+ old , have been taking the drug for 5 - 10 years, also take medication Fosamax, and have High blood pressure. This study is created by eHealthMe based on reports of 20,543 people who have side effects when taking Levoxyl from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on levothyroxine sodium (the active ingredients of Levoxyl) and Levoxyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Interstitial lung disease are also considered in the study.

What is Levoxyl?

Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. (latest outcomes from Levoxyl 21,995 users)

What is Interstitial lung disease?

Interstitial lung disease has been reported by people with rheumatoid arthritis, high blood pressure, preventive health care, lung cancer - non-small cell, atrial fibrillation/flutter (latest reports from 37,186 Interstitial lung disease patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Feb, 23, 2019

20,543 people reported to have side effects when taking Levoxyl.
Among them, 32 people (0.16%) have Interstitial lung disease


Number of reports submitted per year:

Could Levoxyl cause Interstitial lung disease?

Time on Levoxyl when people have Interstitial lung disease *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 100 %
  • 10+ years: 0.0 %

Gender of people who have Interstitial lung disease when taking Levoxyl *:

  • female: 71.88 %
  • male: 28.12 %

Age of people who have Interstitial lung disease when taking Levoxyl *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 7.41 %
  • 50-59: 14.81 %
  • 60+: 77.78 %

Top conditions involved for these people *:

  1. High Blood Pressure: 10 people, 31.25%
  2. Osteoporosis (bones weak and more likely to break): 7 people, 21.88%
  3. Insomnia (sleeplessness): 4 people, 12.50%
  4. Rickets (softening of bones): 4 people, 12.50%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 12.50%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 12.50%
  7. Diabetes: 3 people, 9.38%
  8. Multiple Myeloma (cancer of the plasma cells): 3 people, 9.38%
  9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 9.38%
  10. Pain: 3 people, 9.38%

Top co-used drugs for these people *:

  1. Fosamax: 12 people, 37.50%
  2. Neurontin: 8 people, 25.00%
  3. Zocor: 6 people, 18.75%
  4. Dyazide: 6 people, 18.75%
  5. Prednisone: 6 people, 18.75%
  6. Aspirin: 6 people, 18.75%
  7. Lasix: 4 people, 12.50%
  8. Provigil: 4 people, 12.50%
  9. Synthroid: 4 people, 12.50%
  10. Avonex: 4 people, 12.50%

Top other side effects for these people *:

  1. Weight Decreased: 8 people, 25.00%
  2. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 8 people, 25.00%
  3. High Blood Cholesterol: 8 people, 25.00%
  4. Aortic Arteriosclerosis (hardening of the aortic arteries): 7 people, 21.88%
  5. Spinal Osteoarthritis (joint cartilage loss in spine): 7 people, 21.88%
  6. International Normalised Ratio Increased: 7 people, 21.88%
  7. Spinal Compression Fracture (fracture due to spinal compression on bone): 6 people, 18.75%
  8. Rash Macular (small, flat red spots): 6 people, 18.75%
  9. Rashes (redness): 6 people, 18.75%
  10. Pain In Extremity: 6 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you have Interstitial lung disease while taking Levoxyl?


You are not alone:




Related publications that referenced our studies

Related studies

Drugs that are associated with Interstitial lung disease
Interstitial lung disease (1,716 drugs)
Could your condition cause Interstitial lung disease
Interstitial lung disease (1,518 conditions)
Levoxyl side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Levoxyl
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Levoxyl with similar drugs


What would happen?

Predict new side effects and undetected conditions when you take Levoxyl and have Interstitial lung disease



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.